Member Info for Nolupus

ChrisTOffer,

Talking about shelf life , is this pertinent ?

https://patents.justia.com/patent/10293030

Dallo,

The clinical trial protocol will be very interesting indeed but imo the duration of the trial will be dependant on the number of patients required thus the SPA
Are IMM going for the minimum of 200 patients again like last time ?

Thé race is still on

Tils vs Sng , first to 300p wins

Easyp ,

That's fast track which Imm has and all companies get in Lupus trials but that's for review times after readouts
What Dallo mentioned is different if I am reading him properly

No , and Richard is no pitcher himself :-)

Rock solid batter more like it :-)

Accelerated timescale ??

Could you develop your thoughts on that one please Dallo ?

SalaciousC,

All interferons have different roles in our complex immune system and they are all. Or fully understood at this time so let's wait and see what the data will be on future clinical trials before deciding what is what

As Richard would say ... Data is data and talk is only talk :-)

That's the major question at the moment

New interview out with ifn alpha 2b CEO of better life

https://ca.proactiveinvestors.com/companies/news/924943/betterlife-surges-on-uk-biotech-trial-results-of-interferon-inhalation-treatment-for-coronavirus-924943.html

Any thoughts ?

Interestingly comments from the company CEO and we will be keeping an eye on them and their DR Fish :-)

They are far behind us but we should always keep an open mind whilst looking in our rear view mirror :-)

Dallo,

When you see certain comments about the SP going down by certain members here and on advfn , you may correlate that with a rise in the near future , imo
History repeats :-))

Well anyway, with 4 850 000 shares at 2.18
Their stake is now worth £10 mill 573k

Not bad :-)

https://www.synairgen.com/investors/major-shareholders/

Something's happening anyway

Best of luck, scoredagainststeps

Will just have to wait and see :-)

Talking about tr-1

Where is Sharestring ?

The race is on with Sng

First to 300p wins

John117,

What do you think ?

Eva,
This is not a popularity contest but a BB,
Your credibility or mine is not an issue here ....I don't care If my views are popular or not but I will give them anyway no matter if I am invested or not , they don't change ....
Anyway , bye bye Eva , we will probably see you back here under a different name next time around

Eva, MArie , MariaM etc etc

I said I would ignore you but I always like for things to be factual

1) I am far from being obsessed with you but I do believe the contrary to be true ..

2) In SNG , like in all biotech stocks, the risks involved in readouts are enormous ( people here are well aware of that (140-30p ) On a bad readout
I did Point out to people not to invest more than they could afford to lose and nothing wrong with that advice
I also point out that it's up to everyone to make their own trades after seeing both sides of the coin !!
You keep mentioning a certain Woodstock , as an example but if you take the time to read his posts you will find that he thanked me a lot for giving him a balanced view
So basically you have a biased view which you force on people here and elsewhere but I stick to my guns and opinions and nothing you may say or do will change that .
Au Revoir , as the French would say !

John117,

One could imagine that the drop on Thursday would have got them buying on the market to protect their stake but they did cross the 3% on Thursday /Friday in any case...thus the RNS ..

What is great for us PI is that we can now be confident that the SP won't tank below the range of 160-240 ((((unless very bad news ) as these guys will be there to mop up :-)

All in my opinion of course

CW25,

One could imagine that they were behind the share buying from Acacia and then they bought more on the market afterwards but we just don't know .

Under 3 % they did'nt need to declare anything so we can't really say when exactly they bought in ....

If they bought from Acacia their average would be a hell of a lot less than the £2

If they bought in the last week well they must have an approximate average of circa £2 imv